The Editor's Roundtable: Psoriasis, Inflammation, and Coronary Artery Disease

Vincent E. Friedewald*, Jennifer C. Cather, Kenneth B. Gordon, Arthur Kavanaugh, Paul M. Ridker, William C. Roberts

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

26 Scopus citations
Original languageEnglish (US)
Pages (from-to)1119-1126
Number of pages8
JournalAmerican Journal of Cardiology
Volume101
Issue number8
DOIs
StatePublished - Apr 15 2008

Funding

Dr. Friedewald receives honoraria from Novartis, East Hanover, New Jersey. Dr. Cather receives honoraria from Centocor, Horsham, Pennsylvania; Abbott Laboratories, Abbott Park, Illinois; Genentech, South San Francisco, California; Astellas, Deerfield, Illinois; and Amgen, Thousand Oaks, California. Dr. Gordon receives honoraria and grant support from Abbott Laboratories, Amgen, Centocor, and Genentech. Dr. Kavanaugh has no relevant financial relationships to disclose. Dr. Ridker receives research support from AstraZeneca, Wilmington, Delaware; Novartis; Abbott Laboratories; Sanofi-Aventis, Bridgewater, New Jersey; Amgen; and the National Institutes of Health, Bethesda, Maryland. Dr. Ridker receives royalties from Brigham and Woman’s Hospital, Boston, Massachusetts. Dr. Roberts receives honoraria from Merck, Whitehouse Station, New Jersey; Schering-Plough, Kenilworth, New Jersey; AstraZeneca; and Novartis. This CME activity is supported by an educational grant from Abbott Laboratories, Abbott Park, Illinois.

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this